Trial Profile
A prospective, observational study to evaluate the safety and efficacy of diquafosol (DIQUAS) in glaucoma patients with dry eye syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 31 Mar 2017 New trial record